ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,046 filers reported holding ASTRAZENECA PLC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,704,127 | -97.9% | 39,931 | -97.7% | 0.05% | -97.8% |
| Q2 2023 | $126,618,137 | -12.7% | 1,769,151 | -15.3% | 2.05% | -13.6% |
| Q1 2023 | $144,976,737 | +95827.2% | 2,088,701 | -6.3% | 2.37% | -5.7% |
| Q4 2022 | $151,132 | -99.9% | 2,229,087 | -2.4% | 2.51% | +18.4% |
| Q3 2022 | $125,209,000 | -17.4% | 2,283,175 | -0.5% | 2.12% | -16.6% |
| Q2 2022 | $151,647,000 | +324.1% | 2,295,235 | +325.8% | 2.54% | +432.4% |
| Q1 2022 | $35,758,000 | +22.2% | 539,017 | +7.3% | 0.48% | +55.7% |
| Q4 2021 | $29,264,000 | +17.5% | 502,395 | +21.2% | 0.31% | +19.0% |
| Q3 2021 | $24,903,000 | +13.7% | 414,620 | +13.4% | 0.26% | +22.3% |
| Q2 2021 | $21,911,000 | +1.5% | 365,786 | -15.8% | 0.21% | -8.3% |
| Q1 2021 | $21,596,000 | +8.6% | 434,338 | +9.2% | 0.23% | +8.0% |
| Q4 2020 | $19,892,000 | +395.8% | 397,926 | +443.9% | 0.21% | +373.3% |
| Q3 2020 | $4,012,000 | +4.0% | 73,160 | +0.3% | 0.04% | -2.2% |
| Q2 2020 | $3,856,000 | – | 72,910 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |